anonymous
Guest
anonymous
Guest
They keep saying "end of this week" or "end of next week". Still no approval and the start date is quickly approaching...
They keep saying "end of this week" or "end of next week". Still no approval and the start date is quickly approaching...
The worst case is it isn't approved and Purdue kills your launch!Worst case our start date gets pushed back a few weeks no big deal
The worst case is it isn't approved and Purdue kills your launch!
i imagine they will push for answer this week, if it goes later- training, launch- everything will have to be changed!!Worst case our start date gets pushed back a few weeks no big deal
i imagine they will push for answer this week, if it goes later- training, launch- everything will have to be changed!!
The worst case is it isn't approved and Purdue kills your launch!
My feeling is everything is going to get pushed back they may wait and bring everyone on after national meeting in Feb.
Teva will eat Purdue's lunch once approval happens! Purdue is floundering. New management has ruined the company. They let go a lot of seasoned reps with great relationships in the pain space and their management doesn't understand or know how to adapt to the pain market. Managed care companies, KOL's and many doctors hate Purdue and will jump on board with any other pain company if given the chance! Not discounting that Purdue could be paying off the FDA to delay Teva product.
I'm just ready to get to work and start making some money and win some trips. I'm not worried about a qd opiate pain med. Most pain specialist hate oral qd pain meds.
It's all about the patent and Purdue has several that can lock this drug out. 50/50 shot here at bestI'm just ready to get to work and start making some money and win some trips. I'm not worried about a qd opiate pain med. Most pain specialist hate oral qd pain meds.
I'm just ready to get to work and start making some money and win some trips. I'm not worried about a qd opiate pain med. Most pain specialist hate oral qd pain meds.
Incorrect. FDA can give contigent approval. If they give approval to TEVA then TEVA can market. If they've infringed on Purdue that's not fair to take that business and a pain to recoup. FDA gave contingent approval for Collegiums new drug but must wait for full approval to market. Big concern that Ventrella has not received any approval 6 weeks after planned PDUFA. Sorry for bad news.
what's the hold up?You are misinformed and have no idea what you are talking about, there have been multiple products that got approval this year several weeks or months after PDUFA do some research
Incorrect. FDA can give contigent approval. If they give approval to TEVA then TEVA can market. If they've infringed on Purdue that's not fair to take that business and a pain to recoup. FDA gave contingent approval for Collegiums new drug but must wait for full approval to market. Big concern that Ventrella has not received any approval 6 weeks after planned PDUFA. Sorry for bad news.
date please?Wrong!